COMMUNIQUÉS West-GlobeNewswire

Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer
31/05/2019
In TKI-naïve ROS1+ Patients, Overall Response Rate by Blinded Review is 82 Percent, and 83 Percent at Likely Recommended Phase 2 Dose of 160 mg QD or Above; Median Duration of Response across all Dose Levels Not Yet [...]
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully Combat Cancer Could See [...]
Ultragenyx to Present at Upcoming Investor Conferences
31/05/2019
NOVATO, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]
Surgery Partners, Inc. to Present at the Jefferies 2019 Global Healthcare Conference
31/05/2019
BRENTWOOD, Tenn., May 31, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that management will present at the [...]
Aura Announces Appointment of Al Quong to Its Board of Directors
31/05/2019
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the appointment of Al Quong to its board of directors, subject to regulatory approval. Mr. [...]
Allscripts to present at upcoming investor events
31/05/2019
CHICAGO, May 31, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the following upcoming investor events: Baird 2019 Global Consumer, [...]
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
31/05/2019
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 The NEPA IV formulation was evaluated for safety in the AC setting. Lugano, Switzerland, May 31, 2019 [...]
Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract
31/05/2019
Poster presentation tomorrow, June 1 st at 8:00 am CT in Poster Hall A Conference call and webcast to discuss results Monday, June 3 rd at 8:30 am ET CAMBRIDGE, Mass., May 31, 2019 (GLOBE NEWSWIRE) -- Genocea [...]
Aptose to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
SAN DIEGO and TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
31/05/2019
Reverse stock split intended to bring company into compliance with minimum bid price requirement for maintaining listing on Nasdaq Capital Market EDISON, N.J., May 31, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals [...]
YSS Corp.™ (formerly Solo Growth Corp.) Announces 2019 Construction Update, Name Change to YSS Corp and New Corporate Presentation
31/05/2019
CALGARY, Alberta, May 31, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (TSXV: SOLO) (WKN:A2PBMC) (formerly Solo Growth Corp.), a cannabis retailer operating as YSS TM with the vision to become a premier retailer and the trusted [...]
BioCryst to Present at Upcoming Investor Conferences
31/05/2019
RESEARCH TRIANGLE PARK, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Jefferies 2019 Healthcare Conference in New York on [...]
Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy
31/05/2019
Complete Response rate of 11 percent observed in the LN-145 study in cervical cancer Median duration of response has not been reached at 7.4 month median follow-up in the ongoing study of LN-145 in advanced cervical [...]
Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
STAMFORD, Conn., May 31, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by [...]
Axovant to Present at Upcoming Conferences in June
31/05/2019
BASEL, Switzerland, May 31, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu, M.D., chief executive [...]
ContraFect Announces Publication of Paper on Recent Exebacase Data in Antimicrobial Agents and Chemotherapy Journal
31/05/2019
Exebacase concentrations below the minimum inhibitory concentration (sub-MIC) demonstrated sustained reductions in bacterial fitness and virulence of Staphylococcus aureus YONKERS, N.Y., May 31, 2019 (GLOBE NEWSWIRE [...]
Iovance Biotherapeutics to Participate in Upcoming Conferences in June
31/05/2019
SAN CARLOS, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Pages